196 related articles for article (PubMed ID: 21711443)
1. Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants.
Maratea D; Fadda V; Trippoli S; Messori A
J Thromb Haemost; 2011 Sep; 9(9):1868-70. PubMed ID: 21711443
[No Abstract] [Full Text] [Related]
2. Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation.
Messori A; Fadda V; Maratea D; Trippoli S; Marinai C
Int J Clin Pharmacol Ther; 2015 Mar; 53(3):211-9. PubMed ID: 25295718
[TBL] [Abstract][Full Text] [Related]
3. Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison.
Kwok CS; Pradhan S; Yeong JK; Loke YK
Chest; 2013 Aug; 144(2):593-600. PubMed ID: 23519234
[TBL] [Abstract][Full Text] [Related]
4. [Venous thromboembolism. Currently it is worthwhile to use anticoagulants longer].
Einecke D
MMW Fortschr Med; 2013 Apr; 155(6):26-7. PubMed ID: 23700693
[No Abstract] [Full Text] [Related]
5. [New direct oral anticoagulants and venous thromboprophylaxis].
Degirmenci SE; Steib A
Rev Prat; 2013 Sep; 63(7):976-9. PubMed ID: 24167901
[TBL] [Abstract][Full Text] [Related]
6. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
Kakkos SK; Kirkilesis GI; Tsolakis IA
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
[TBL] [Abstract][Full Text] [Related]
7. New oral anticoagulants: a practical guide for clinicians.
Wittkowsky AK
J Thromb Thrombolysis; 2010 Feb; 29(2):182-91. PubMed ID: 19888552
[TBL] [Abstract][Full Text] [Related]
8. Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients.
Riva N; Donadini MP; Bozzato S; Ageno W
Thromb Res; 2013 Jan; 131 Suppl 1():S67-70. PubMed ID: 23452747
[TBL] [Abstract][Full Text] [Related]
9. In the pipeline: new oral anticoagulants for the prevention of venous thromboembolism.
Farley TM; Lewis D; Macaulay TE
Orthopedics; 2009 Jan; 32(1):35. PubMed ID: 19226034
[No Abstract] [Full Text] [Related]
10. The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.
Rachidi S; Aldin ES; Greenberg C; Sachs B; Streiff M; Zeidan AM
Expert Rev Hematol; 2013 Dec; 6(6):677-95. PubMed ID: 24219550
[TBL] [Abstract][Full Text] [Related]
11. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Huisman MV; Quinlan DJ; Dahl OE; Schulman S
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Skjøth F; Larsen TB; Rasmussen LH; Lip GY
Thromb Haemost; 2014 May; 111(5):981-8. PubMed ID: 24577485
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.
Prandoni P; Temraz S; Taher A
Semin Hematol; 2014 Apr; 51(2):121-30. PubMed ID: 24861796
[TBL] [Abstract][Full Text] [Related]
14. [Direct acting oral anticoagulants in venous thromboembolism].
Walti C; Bächli E
Praxis (Bern 1994); 2015 Jul; 104(15):771-80. PubMed ID: 26204334
[No Abstract] [Full Text] [Related]
15. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
16. Implications of new anticoagulants in primary practice.
Perez A; Eraso LH; Merli GJ
Int J Clin Pract; 2013 Feb; 67(2):139-56. PubMed ID: 23305476
[TBL] [Abstract][Full Text] [Related]
17. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS
Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
[TBL] [Abstract][Full Text] [Related]
18. New oral anticoagulants: not quite there yet.
Karthikeyan G; Eikelboom JW; Hirsh J
Pol Arch Med Wewn; 2009; 119(1-2):53-8. PubMed ID: 19341179
[TBL] [Abstract][Full Text] [Related]
19. Direct oral anticoagulants in the management of venous thromboembolism--evidence from major clinical trials.
Holy EW; Beer JH
Semin Hematol; 2014 Apr; 51(2):131-8. PubMed ID: 24861797
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Loke YK; Kwok CS
J Clin Pharm Ther; 2011 Feb; 36(1):111-24. PubMed ID: 21198726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
